Staff turnover in EUR18,227168,30893,89459,04512,145
Staff turnover in EUR18,227168,30893,89459,04512,145
The share: stated in EUR20212022202320242025
Shares outstanding (in mn.)34.1846.5846.6046.7846.78
Dividend per share-----
Basic earnings per share-0.80-0.53-0.44-0.42-0.91
P/L in EUR million under IAS/IFRS20212022202320242025
Turnover1.718.59.96.81.5
Operating income (EBIT)-25.6-17.2-27.1-20.7-42.1
Earnings before taxes-26.1-17.8-20.3-19.4-41.2
Annual net profit/ loss-26.1-19.7-20.3-19.4-42.3
Balance sheet in EUR million under IAS/IFRS20212022202320242025
Assets
Total current assets9.087.956.647.628.3
Total fixed assets12.712.713.713.29.8
Total assets21.7100.670.460.738.1
Liabilities
Total short-term liabilities14.927.919.88.011.2
Total long-term liabilities0.16.01.221.937.8
Total provisions0.00.00.00.00.0
Equity capital6.766.649.330.9-10.9
Total liabilities21.7100.670.460.738.1
Management:
Dongzhou Jeffery Liu
Andras Strassz
George Badescu
Jörg Kemkowski
Peter Willinger
Board:
Karl Benedikt Biesinger
Birgit Kudlek
Georg F. Baur
Klaus Schollmeier
Mathias Hothum
Yan Xia
Shareholding in %:
Baader Bank AG (Investment Management) 0.71
Huadong Medicine Co., Ltd. 34.90
Universal Investment Luxembourg SA 0.32
dievini Hopp BioTech holding GmbH & Co. KG 44.10
Freefloat 19.97
Address: Gregor-Mendel-Strasse 22, 68526 Ladenburg
T: +49-6209-1009-0
F: +49-6209-1009-19
I: http://heidelberg-pharma.com
E: